5-Mercury derivatives of 5,6-dihydroprostacyclin compounds

Information

  • Patent Grant
  • 4170598
  • Patent Number
    4,170,598
  • Date Filed
    Monday, June 19, 1978
    45 years ago
  • Date Issued
    Tuesday, October 9, 1979
    44 years ago
Abstract
Mercury derivatives of 5,6-dihydroprostacyclins are disclosed, illustrated for example by ##STR1## wherein G is nitrato, iodo, chloro, bromo, acetato, trifluoroacetato, or benzoato, and wherein .about. indicates alpha or beta configuration, said products having pharmacological activity.
Description

BACKGROUND OF THE INVENTION
This invention relates to products having prostacyclin-like structure and to processes for preparing them. In particular this invention relates to 5-mercury derivatives of 5,6-dihydroprostacyclin compounds and to processes for preparing them.
The essential material for this application, including the background of the invention, the disclosure of the invention, and the description of the preferred embodiments, including Prepartions and Examples, is incorporated by reference from commonly owned U.S. Pat. No. 4,125,712, especially columns 33-34, 52-54, and 84-105, under the proviso of M.P.E.P. 608.01(p).
SUMMARY OF THE INVENTION
It is the purpose of this invention to provide novel products having pharmacological activity and utility as intermediates. It is a further purpose to provide processes for preparing these products and their intermediates.
The terms L, Q.sub.2, etc. as used hereinafter are as defined in the Table of Definitions herein.
TABLE
Definition of Terms for Formulas
G is nitrato, iodo, chloro, bromo, acetato, trifluoroacetato, or benzoato.
L is (1) a valence bond, (2) --(CH.sub.2).sub.d --wherein d is one to 5 inclusive, (3) --(CH.sub.2).sub.t --CF.sub.2 --wherein t is 2, 3, or 4, (4)--CH.sub.2 --CH.dbd.CH--A--wherein A is a valence bond or --(CH.sub.2).sub.h --wherein h is one, 2, or 3, or (5) --CH.sub.2 --O--CH.sub.2 --Y--wherein Y is a valence bond or --(CH.sub.2).sub.k --wherein k is one or 2.
Q.sub.2 is ##STR2## wherein R.sub.3 is hydrogen or alkyl of one to 4 carbon atoms, inclusive, and wherein R.sub.4 is hydrogen, tetrahydropyran-2-yl, tetrahydrofuranyl, 1-ethoxyethyl or a group of the formula ##STR3## wherein R.sub.8 is alkyl of one to 18 carbon atoms, inclusive, cycloalkyl of 3 to 10 carbon atoms, inclusive, aralkyl of 7 to 12 carbon atoms, inclusive, aralkyl of 7 to 12 carbon atoms, inclusive, phenyl, or phenyl substituted with one, 2, or 3 alkyl of one to 4 carbon atoms, inclusive, wherein R.sub.9 and R.sub.10 are the same or different, being hydrogen, alkyl of one to 4 carbon atoms, inclusive, phenyl or phenyl substituted with one, 2, or 3 alkyl of one to 4 carbon atoms, inclusive, or, when R.sub.9 and R.sub.10 are taken together, --(CH.sub.2).sub.a --or --(CH.sub.2).sub.b --O--(CH.sub.2).sub.c --wherein "a" is 3, 4, or 5, b is one, 2, or 3, and c is one, 2, or 3 with the proviso that b plus c is 2, 3, or 4, and wherein R.sub.11 is hydrogen or phenyl.
R.sub.3 and R.sub.4 are as defined above for Q.sub.2.
is ##STR4## wherein R.sub.4 is as defined above for Q.sub.2. R.sub.25 is
(1) ##STR5## wherein C.sub.g H.sub.2.sbsb.g is alkylene of one to 9 carbon atoms, inclusive, with one to 5 carbon atoms, inclusive, in the chain between --CR.sub.5 R.sub.6 --and terminal methyl, wherein R.sub.5 and R.sub.6 ar hydrogen, alkyl of one to 4 carbon atoms, inclusive, or fluoro, being the same or different, with the proviso that one of R.sub.5 and R.sub.6 is fluoro only when the other is hydrogen or fluoro;
(2) ##STR6## wherein R.sub.5 and R.sub.6 are as defined above with the proviso that neither R.sub.5 nor R.sub.6 is fluoro when Z is oza (--O--); wherein Z represents an oxa atom (--0--) or C.sub.j H.sub.2.sbsb.j wherein C.sub.j H.sub.2.sbsb.j is a valence bond or alkylene of one to 9 carbon atoms, inclusive, with one to 6 carbon atoms, inclusive between --CR.sub.5 R.sub.6 --and the phenyl ring; wherein T is alkyl of one to 4 carbon atoms, inclusive, fluoro, chloro, trifluoromethyl, or --OR.sub.7 --wherein R.sub.7 is alkyl of one to 4 carbon atoms, inclusive, and s is zero, one, 2, or 3, with the proviso that not more than two T's are other than alkyl and when s is 2 or 3 the T's are either the same or different; or
(3) ##STR7## R.sub.30 is (1) --COOR.sub.19
(2) --ch.sub.2 oh
(3)--ch.sub.2 n(r.sub.18).sub.2
(4) ##STR8## (5) ##STR9## wherein R.sub.19 is (a) alkyl of one to 12 carbon atoms, inclusive,
(b) cycloalkyl of 3 to 10 carbon atoms, inclusive,
(c) aralkyl of 7 to 2 carbon atoms, inclusive,
(d) phenyl.
(e) phenyl substituted with one, 2, or 3 chloro or alkyl of one to 4 carbon atoms, inclusive, ##STR10## wherein R.sub.34 is phenyl, p-bromophenyl, p-biphenylyl, p-nitrophenyl, p-benzamidophenyl, or 2-naphthyl, and wherein R.sub.35 is hydrogen or benzoyl,
(m) hydrogen; or
(n) a pharmacologically acceptable cation; and wherein R.sub.18 is hydrogen, alkyl of one to 12 carbon atoms, inclusive, benzyl, or phenyl, being the same or different.
R.sub.36 is the same as R.sub.30 except that it does not include salts in which R.sub.19 of --COOR.sub.19 is a pharmacologically acceptable cation.
X is trans--CH.dbd.CH--, cis--CH.dbd.CH--, --C.tbd.C--, or --CH.sub.2 CH.sub.2 --.
The symbol .about. (wavy line) indicates attachment in alpha or beta configuration.
Accordingly there are provided mercury compounds of the formula ##STR11##
wherein G is nitrato, iodo, chloro, bromo, acetato, trifluoroacetato, or benzoato;
and wherein L, Q.sub.2, , R.sub.25 , R.sub.30, X, and .about. are as defined above.
There are also provided mercury compounds of the formula ##STR12## wherein L, Q.sub.2, , R.sub.25, X, and .about. are as defined above.
The novel mercury compounds disclosed herein are useful for pharmacological purposes. They have antiprotozoal and antisyphilitic activity and are consequently effective in treating streptococci and staphylococci. They have antimicrobial activity and are useful for topical antiseptic treatment for animals, including humans, useful domestic animals, pets, zoological specimens, and laboratory animals. They are further useful in ophthalmiatrics.
For these purposes, these mercury compounds are preferably administered topically, for example in alcoholic solution at 0.002 to 0.01% concentration with a benzalkonium chloride as a preservative, or as a lotion, cream, or ointment in 0.5-5.0% concentration in combination with the usual pharmaceutically acceptable diluents. The exact application and concentration depends on such factors as the age, weight and condition of the subject.
Certain mercury compounds within the scope of formula XXXV are preferred for optimum biological response specificity, potency, and duration of activity. For example it is preferred that Q.sub.2 be ##STR13## wherein R.sub.4 is hydrogen; it is further preferred that L be trimethylene. When R.sub.3 is alkyl, it is preferred that R.sub.3 be methyl. Likewise, as to R.sub.30, when R.sub.19 in -COOR.sub.19 is alkyl, it is preferred that R.sub.19 be alkyl of one to 4 carbon atoms, especially methyl. Another preference is that G be chloro or acetato.
Claims
  • 1. A mercury compound of the formula ##STR14## wherein G is nitrato, iodo, chloro, bromo, acetato, trifluoracetato, or benzoato;
  • wherein L is (1) a valence bond, (2) --(CH.sub.2).sub.d --wherein d is one to 5 inclusive, (3) --(CH.sub.2).sub.t --CF.sub.2 wherein t is 2, 3, or 4, (4) --CH.sub.2 --CH.dbd.CH--A-- wherein A is a valence bond or --(CH.sub.2).sub.h --wherein h is one, 2, or 3, or (5) --CH.sub.2 --O--CH.sub.2 --Y--wherein Y is a valence bond or --(CH.sub.2).sub.k --wherein k is one or 2; wherein Q.sub.2 is ##STR15## wherein R.sub.3 is hydrogen or alkyl of one to 4 carbon atoms, inclusive, and wherein R.sub.4 is hydrogen, tetrahydropyranyl, tetrahydrofuranyl, 1-ethoxyethyl or a group of the formula ##STR16## wherein R.sub.8 is alkyl of one to 18 carbon atoms, inclusive, cycloalkyl of 3 to 10 carbon atoms, inclusive, aralkyl of 7 to 12 carbon atoms, inclusive, phenyl, or phenyl substituted with one, 2, or 3 alkyl of one to 4 carbon atoms, inclusive, wherein R.sub.9 and R.sub.10 are taken together, --(CH.sub.2).sub.a --or --(CH.sub.2).sub.b --O--(CH.sub.2).sub.c --wherein a is 3, 4, or 5, b is one, 2, or 3, and c is one, 2, or 3 with the proviso that b plus c is 2, 3, or 4, and wherein R.sub.11 is hydrogen or phenyl;
  • wherein R.sub.22 is ##STR17## wherein R.sub.4 is as defined above; wherein R.sub.25 is
  • (1) ##STR18## wherein C.sub.g H.sub.2.sbsb.g is alkylene of one to 9 carbon atoms, inclusive, with one to 5 carbon atoms, inclusive in the chain between --CR.sub.5 R.sub.6 --and terminal methyl, wherein R.sub.5 and R.sub.6 are hydrogen, alkyl of one to 4 carbon atoms, inclusive, or fluoro, being the same or different, with the proviso that one of R.sub.5 and R.sub.6 is fluoro only when the other is hydrogen or fluoro;
  • (2) ##STR19## wherein R.sub.5 and R.sub.6 are as defined above with the proviso that neither R.sub.5 nor R.sub.6 is fluoro when Z is oxa (--O--); wherein Z represents an oxa atom (--O--) or C.sub.j H.sub.2j wherein C.sub.j H.sub.2j is a valence bond or alkylene of one to 9 carbon atoms, inclusive, substituted with zero, one, or 2 fluoro, with one to 6 carbon atoms, inclusive between --CR.sub.5 R.sub.6 --and the phenyl ring; wherein T is alkyl of one to 4 carbon atoms, inclusive, fluoro, chloro, trifluoromethyl, or --OR.sub.7 wherein R.sub.7 is alkyl of one to 4 carbon atoms, inclusive, and s is zero, one, 2, or 3, with the proviso that not more than two T's are other than alkyl and when s is 2 or 3 the T's are either the same or different; or
  • (3) ##STR20## wherein R.sub.30 is (1) -COOR.sub.19
  • (2) -ch.sub.2 oh
  • (3) -ch.sub.2 n(r.sub.18).sub.2 ##STR21## wherein R.sub.19 is (a) alkyl of one to 12 carbon atoms, inclusive,
  • (b) cycloalkyl of 3 to 10 carbon atoms, inclusive,
  • (c) aralkyl of 7 to 12 carbon atoms, inclusive,
  • (d) phenyl,
  • (e) phenyl substituted with one, 2, or 3 chloro or alkyl of one to 4 carbon atoms, inclusive; ##STR22## wherein R.sub.34 is phenyl, p-bromophenyl, p-biphenylyl, p-nitrophenyl, p-benzamidophenyl, or 2-naphthyl, and wherein R.sub.35 is hydrogen or benzoyl,
  • (m) hydrogen, or
  • (n) a pharmacologically acceptable cation; and wherein
  • R.sub.18 is hydrogen, alkyl of one to 12 carbon atoms, inclusive, benzyl, or phenyl, being the same or different;
  • wherein X is trans--CH.dbd.CH--, cis--CH.dbd.CH--, --C.tbd.C--, or --CH.sub.2 CH.sub.2 --; and wherein .about. indicates attachment in alpha or beta configuration.
  • 2. 5-Chloromercurio-9-deoxy-6.xi.,9.alpha.-epoxy-PGF.sub.1, methyl ester, compounds according to claim 1.
  • 3. A mercury compound of the formula ##STR23## wherein L is --(CH.sub.2).sub.d --or --CH.sub.2 O--CH.sub.2 --Y-- wherein d is one to 5, inclusive, and Y is a valence bond or --(CH.sub.2).sub.k -- where k is one or 2; wherein R.sub.2 is
  • (1) ##STR24## wherein C.sub.g H.sub.2.sbsb.g is alkylene of one to 9 carbon atoms, inclusive, with one to 5 carbon atoms, inclusive, in the chain between --CR.sub.5 R.sub.6 -- and terminal methyl, wherein R.sub.5 and R.sub.6 are hydrogen, alkyl of one to 4 carbon atoms, inclusive, or fluoro, being the same or different, with the proviso that one of R.sub.5 and R.sub.6 is fluoro only when the other is hydrogen or fluoro; or
  • (2) ##STR25## wherein R.sub.5 and R.sub.6 are as defined above with the proviso that neither R.sub.5 nor R.sub.6 is fluoro when Z is oxa (--O--); wherein Z represents an oxa atom (--O--) or C.sub.j H.sub.2j wherein C.sub.j H.sub.2j is a valence bond or alkylene of one to 9 carbon atoms, inclusive, with one to 6 carbon atoms, inclusive between --CR.sub.5 R.sub.6 -- and the phenyl ring; wherein T is alkyl of one to 4 carbon atoms, inclusive, fluoro, chloro, trifluoromethyl, or --OR.sub.7 wherein R.sub.7 is hydrogen or alkyl of one to 4 carbon atoms, inclusive, and s is zero, one, 2, or 3, with the proviso that not more than two T's are other than alkyl and when s is 2 or 3 the T's are either the same or different; wherein Q.sub.3 is ##STR26## wherein R.sub.3 is hydrogen or alkyl of one to 4 carbon atoms, inclusive; and wherein .about. indicates attachment in alpha or beta configuration.
  • 4. 5-Chloromercurio-9-deoxy-6.xi.,9.alpha.-epoxy-PGF.sub.1, methyl ester, less polar isomer, a compound according to claim 2.
  • 5. 5-Chloromercurio-9-deoxy-6.xi.,9.alpha.-epoxy-PGF.sub.1, methyl ester, more polar isomer, a compound according to claim 2.
  • 6. 5-Chloromercurio-9-deoxy-6.xi.,9.alpha.-epoxy-17-phenyl-18,19,20-trinor-PGF.sub.1, methyl ester, compounds according to claim 1.
  • 7. 5-Chloromercurio-9-deoxy-6.xi.,9.alpha.-epoxy-16,16-dimethyl-PGF.sub.1, methyl ester, compounds according to claim 1.
  • 8. 5-Chloromercurio-9-deoxy-6.xi.,9.alpha.-epoxy-16-phenoxy-17,18,19,20-tetranor-PGF.sub.1, compounds according to claim 1.
  • 9. 5-Chloromercurio-9-deoxy-6.xi.,9.alpha.-epoxy-PGF.sub.1, compounds according to claim 1.
  • 10. 5-Acetatomercurio-9-deoxy-6.xi., 9.alpha.-epoxy-PGF.sub.1, methyl ester, compounds according to claim 1.
CROSS REFERENCE TO RELATED APPLLICATIONS

This is a division, of application Ser. No. 857,236, filed Dec. 5, 1977 now U.S. Pat. No. 4,125,712, which is a continuation-in-part of copending application Ser. No. 788,146 filed Apr 19, 1977, now abandoned which was a continuation-in-part of then copending applicaton Ser. No. 691,400 filed June 1, 1976 now abandoned.

Non-Patent Literature Citations (1)
Entry
johnson et al., J.A.C.S., 99:12, Jun. 8, 1977, pp. 4182-4184.
Divisions (1)
Number Date Country
Parent 857236 Dec 1977
Continuation in Parts (2)
Number Date Country
Parent 788146 Apr 1977
Parent 691400 Jun 1976